High triglyceride causes: Difference between revisions

Jump to navigation Jump to search
Line 36: Line 36:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
| '''Drug Side Effect'''
|bgcolor="Beige"| [[Abiraterone]], [[Amprenavir]], [[atazanavir|atazanavir sulfate]], [[atypical  antipsychotics]], [[bendrofluazide]], [[beta-blockers]], [[bexarotene]], [[chlorthalidone]], [[clomiphene]], [[colesevelam|colesevelam hydrochloride]], [[colestyramine]], [[combined oral contraceptive pill]], [[desvenlafaxine]], [[diuretics]], [[Drospirenone and Ethinyl estradiol]], [[Efavirenz]], [[estrogen replacement  therapy]], [[febuxostat]], [[fosamprenavir]], [[glucocorticoids]], [[hydrochlorothiazide]], [[interferon alpha]], [[Interferon gamma]],  [[linagliptin]], [[lopinavir]], [[Medroxyprogesterone]],  [[mirtazapine]], [[non-nucleoside reverse  transcriptase inhibitors]], [[Norethindrone acetate and Ethinyl estradiol]], [[Norgestimate and Ethinyl estradiol]], [[Norgestrel and Ethinyl estradiol]], [[olanzapine]], [[isotretinoin|oral isotretinoin]], [[propofol]], [[protease inhibitors]], [[raloxifene]], [[ritonavir]], [[saquinavir]], [[tamoxifen]], [[tazarotene]], [[temsirolimus]], [[tipranavir]], [[tocilizumab]], [[Tretinoin]]
|bgcolor="Beige"| [[Abiraterone]], [[Amprenavir]], [[atazanavir|atazanavir sulfate]], [[atypical  antipsychotics]], [[bendrofluazide]], [[beta-blockers]], [[bexarotene]], [[chlorthalidone]], [[clomiphene]], [[colesevelam|colesevelam hydrochloride]], [[colestyramine]], [[combined oral contraceptive pill]], [[desvenlafaxine]], [[diuretics]], [[Drospirenone and Ethinyl estradiol]], [[Efavirenz]], [[estrogen replacement  therapy]], [[febuxostat]], [[fosamprenavir]], [[glucocorticoids]], [[hydrochlorothiazide]], [[interferon alpha]], [[Interferon gamma]],  [[linagliptin]], [[lopinavir]], [[Medroxyprogesterone]],  [[mirtazapine]], [[non-nucleoside reverse  transcriptase inhibitors]], [[Norethindrone acetate and Ethinyl estradiol]], [[Norgestimate and Ethinyl estradiol]], [[Norgestrel and Ethinyl estradiol]], [[olanzapine]], [[isotretinoin|oral isotretinoin]], [[propofol]], [[protease inhibitors]], [[raloxifene]], [[ritonavir]], [[Ruxolitinib]],[[saquinavir]], [[tamoxifen]], [[tazarotene]], [[temsirolimus]], [[tipranavir]], [[tocilizumab]], [[Tretinoin]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"

Revision as of 16:43, 21 January 2015

Triglyceride Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Biochemistry

Physiology

Clinical Correlation

Triglyceride Laboratory Test

High Triglyceride

Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications
History and Symptoms
Physical Examination

Low Triglyceride

Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications

Treatment

Lifestyle modification

Medical Therapy

Primary Prevention

Secondary Prevention

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

High triglyceride causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of High triglyceride causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on High triglyceride causes

CDC on High triglyceride causes

High triglyceride causes in the news

Blogs on High triglyceride causes

Directions to Hospitals Treating Triglyceride

Risk calculators and risk factors for High triglyceride causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, M.B.B.S. [2]; Ogheneochuko Ajari, MB.BS, MS [3]

Overview

Hypertriglyceridemia can occur due to various causes, including genetics, familial, metabolic and drugs.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Hypertriglyceridemia does not have life threatening causes.

Common Causes

Causes by Organ System

Cardiovascular Alström syndrome, apoprotein E deficiency, chylomicron levels raised (plasma), familial chylomicronemia, familial combined hyperlipidemia, familial hypertriglyceridemia, hyperlipoproteinemia, familial type 5, intermediate density lipoprotein levels raised (plasma or serum), metabolic syndrome, Reaven syndrome X
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic Systemic lupus erythematosus
Drug Side Effect Abiraterone, Amprenavir, atazanavir sulfate, atypical antipsychotics, bendrofluazide, beta-blockers, bexarotene, chlorthalidone, clomiphene, colesevelam hydrochloride, colestyramine, combined oral contraceptive pill, desvenlafaxine, diuretics, Drospirenone and Ethinyl estradiol, Efavirenz, estrogen replacement therapy, febuxostat, fosamprenavir, glucocorticoids, hydrochlorothiazide, interferon alpha, Interferon gamma, linagliptin, lopinavir, Medroxyprogesterone, mirtazapine, non-nucleoside reverse transcriptase inhibitors, Norethindrone acetate and Ethinyl estradiol, Norgestimate and Ethinyl estradiol, Norgestrel and Ethinyl estradiol, olanzapine, oral isotretinoin, propofol, protease inhibitors, raloxifene, ritonavir, Ruxolitinib,saquinavir, tamoxifen, tazarotene, temsirolimus, tipranavir, tocilizumab, Tretinoin
Ear Nose Throat No underlying causes
Endocrine Cushing's syndrome, diabetes mellitus, hypothyroidism, insulin resistance, metabolic syndrome, polycystic ovary syndrome, Reaven syndrome X
Environmental No underlying causes
Gastroenterologic Acute pancreatitis, Alagille syndrome, carnitine palmitoyltransferase 1 deficiency, cholesteryl ester storage disease, glycogen storage disease type 1, glycogenosis type 1a, liver cirrhosis, non-alcoholic fatty liver disease
Genetic Alagille syndrome, Alström syndrome, apoprotein E deficiency, carnitine palmitoyltransferase 1 deficiency, cholesteryl ester storage disease, congenital generalized lipodystrophy type 1, deficiency of apolipoprotein C2 , familial chylomicronemia, familial combined hyperlipidemia, familial histiocytic reticulosis, familial hypertriglyceridemia, fish eye disease, glycogen storage disease type 1, glycogenosis type 1a, hyperlipoproteinemia, familial type 5, lecithin cholesterol acyltransferase deficiency, metabolic syndrome, Niemann-Pick disease type B, Reaven syndrome X, sphingomyelinase deficiency, Tangier disease
Hematologic Familial histiocytic reticulosis
Iatrogenic Parenteral nutrition
Infectious Disease No underlying causes
Musculoskeletal/Orthopedic Systemic lupus erythematosus
Neurologic Niemann-Pick disease type B, sphingomyelinase deficiency
Nutritional/Metabolic Alcohol, apoprotein E deficiency, chylomicron levels raised (plasma), deficiency of apolipoprotein C2, familial chylomicronemia, familial combined hyperlipidemia, familial hypertriglyceridemia, glycogen storage disease type 1, glycogenosis type 1a, high carbohydrate or high glycemic index, hyperlipoproteinemia, familial type 5, intermediate density lipoprotein levels raised (plasma or serum), lipodystrophy, lipoprotein lipase deficiency, metabolic syndrome, obesity, Reaven syndrome X, Tangier disease, very low density lipoprotein levels raised (plasma or serum), vitamin E deficiency, familial isolated
Obstetric/Gynecologic Polycystic ovary syndrome, pregnancy
Oncologic No underlying causes
Ophthalmologic Diabetes mellitus, Lecithin cholesterol acyltransferase deficiency
Overdose/Toxicity Alcohol
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte Chronic kidney disease, chronic renal insufficiency, diabetes mellitus, nephrotic syndrome, systemic lupus erythematosus
Rheumatology/Immunology/Allergy Macrophage activation syndrome, metabolic syndrome, paraproteinemias, Reaven syndrome X, systemic lupus erythematosus
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous Alcohol

Causes in Alphabetical Order

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 Kolovou GD, Anagnostopoulou KK, Kostakou PM, Bilianou H, Mikhailidis DP (2009). "Primary and secondary hypertriglyceridaemia". Curr Drug Targets. 10 (4): 336–43. PMID 19355858.
  2. Fallat RW, Glueck CJ (1976). "Familial and acquired type V hyperlipoproteinemia". Atherosclerosis. 23 (1): 41–62. PMID 1078394.

Template:WH Template:WS